Recall
FDAHealthMarch 27, 2026

Appco Pharma LLC — Prazosin Hydrochloride Capsules, USP, 1mg, 100-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ, Manufactured by: Appco Pharma LLC, Piscataway, NJ, NDC 70377-

⚠️ cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
March 27, 2026

U.S.A. Nationwide

What's affected?

Product
Prazosin Hydrochloride Capsules, USP, 1mg, 100-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ, Manufactured by: Appco Pharma LLC, Piscataway, NJ, NDC 70377-066-11.
Lot code
2404160C

Additional details

Lot:2404160C, Exp.:2026/MAR; 2406253C, Exp.:2026/MAY; 2407311C, Exp.: 2026/JUL; 2407312C, Exp.:2026/JUL; 2408350C, Exp.:2026/JUL; 2505172C, Exp.:2027/MAY; 2506191C, Exp.: 2027/JUN.

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 88,008 bottles- 100's count.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.